Oramed Pharmaceuticals Inc. Stock Analysis & AI Score
Oramed Pharmaceuticals Inc. (ORMP) has an ST Score of 65.0 (B), driven by its Profitability (A+) and held back by its Financial Strength (B-). Analysts rate it Buy.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Oramed Pharmaceuticals Inc. (ORMP) has an ST Score of 65.0 (B), driven by its Profitability (A+) and held back by its Financial Strength (B-). Analysts rate it Buy.
- Strongest
- ProfitabilityA+
- Weakest
- Financial StrengthB-
All factor grades
- ProfitabilityA+
- MomentumA-
- GrowthB
- ValuationB-
- Financial StrengthB-
- Piotroski3/9
Contact
ORMP stock: frequently asked questions
What is ORMP's ST Score?
Oramed Pharmaceuticals Inc. (ORMP) has an ST Score of 65.0 (B), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is ORMP a buy, hold, or sell?
Analysts rate ORMP a Buy. Our ST Score grades it B (65.0/100). The ST Score is a data-driven signal, not a recommendation.
What are ORMP's factor grades?
Valuation B-, Profitability A+, Financial Strength B-, Momentum A-, Growth B.
What is ORMP's valuation grade?
Oramed Pharmaceuticals Inc. (ORMP) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is ORMP's growth grade?
Oramed Pharmaceuticals Inc. (ORMP) earns a growth grade of B, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is ORMP's profitability grade?
Oramed Pharmaceuticals Inc. (ORMP) earns a profitability grade of A+, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is ORMP's financial strength grade?
Oramed Pharmaceuticals Inc. (ORMP) earns a financial strength grade of B-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is ORMP's Piotroski score?
Oramed Pharmaceuticals Inc. (ORMP) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.